A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with advanced or recurrent non-squamous non-small cell lung cancer

被引:0
|
作者
Yabuki, Yohei [1 ]
Otsuka, Kenji [1 ]
Ogino, Hirokazu [1 ]
Takeuchi, Eiji [2 ]
Haku, Takashi [3 ]
Kanematsu, Takanori [4 ]
Nishimura, Naoki [5 ]
Toyoda, Yuko [6 ]
Hanibuchi, Masaki [7 ]
Mitsuhashi, Atsushi [1 ]
Tsukazaki, Yuki [1 ]
Ozaki, Ryohiko [1 ]
Yoneda, Hiroto [1 ]
Nokihara, Hiroshi [1 ]
Nisihioka, Yasuhiko [1 ]
机构
[1] Tokushima Univ Hosp, Resp Med & Rheumatol, Tokushima, Japan
[2] Natl Hosp Org Kochi Hosp, Dept Clin Invest, Kochi, Japan
[3] Tokushima Prefectural Cent Hosp, Resp Med, Tokushima, Japan
[4] Japanese Red Cross Matsuyama Hosp, Resp Med, Matsuyama, Ehime, Japan
[5] St Lukes Int Hosp, Thorac Ctr, Tokyo, Japan
[6] Japanese Red Cross Kochi Hosp, Internal Med, Kochi, Japan
[7] Shikoku Cent Hosp, Resp Med, Matsuyama, Ehime, Japan
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
AP08-282
引用
收藏
页码:300 / 300
页数:1
相关论文
共 50 条
  • [21] A multicenter, open-label, phase IIIB trial of erlotinib in patients with advanced non-small cell lung cancer
    Hainsworth, J
    Spigel, D
    O'Neill, V
    Klencke, B
    LUNG CANCER, 2005, 49 : S246 - S247
  • [22] Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients
    Chen, Yongshun
    Wen, Qinglian
    Liu, Hao
    Ao, Rui
    Wu, Xiaoyuan
    Guo, Leiming
    Wang, Wen
    He, Chunyu
    Wang, Jianhua
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 553 - 557
  • [23] Phase I Study of Carboplatin Combined with Pemetrexed for Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Azuma, Koichi
    Zaizen, Yoshiaki
    Yamashita, Fumie
    Yoshida, Tsukasa
    Naito, Yoshiko
    Okayama, Yusuke
    Miyamoto, Maki
    Hoshino, Tomoaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 472 - 478
  • [24] A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
    S. Verma
    S. Chitikela
    V. Singh
    S. Khurana
    D. Pushpam
    D. Jain
    S. Kumar
    Y. Gupta
    P. S. Malik
    Medical Oncology, 40
  • [25] A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
    Verma, S.
    Chitikela, S.
    Singh, V.
    Khurana, S.
    Pushpam, D.
    Jain, D.
    Kumar, S.
    Gupta, Y.
    Malik, P. S.
    MEDICAL ONCOLOGY, 2023, 40 (07)
  • [26] An Open-Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non-Small Cell Lung Cancer
    Patil, Pradnya Dinkar
    Shapiro, Marc
    Sadraei, Nooshin Hashemi
    Pennell, Nathan A.
    ONCOLOGIST, 2019, 24 (04): : 457 - E126
  • [27] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Tamiya, Motohiro
    Tamiya, Akihiro
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    Yoh, Kiyotaka
    Goto, Koichi
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Abe, Tetsuya
    Tanaka, Hiroshi
    Daga, Haruko
    Takeda, Koji
    Hirashima, Tomonori
    Atagi, Shinji
    MEDICAL ONCOLOGY, 2016, 33 (01) : 1 - 7
  • [28] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Motohiro Tamiya
    Akihiro Tamiya
    Hiroyasu Kaneda
    Kazuhiko Nakagawa
    Kiyotaka Yoh
    Koichi Goto
    Hiroaki Okamoto
    Tsuneo Shimokawa
    Tetsuya Abe
    Hiroshi Tanaka
    Haruko Daga
    Koji Takeda
    Tomonori Hirashima
    Shinji Atagi
    Medical Oncology, 2016, 33
  • [29] Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)
    Patel, J. D.
    Hensing, T. A.
    Rademaker, F.
    Hart, E.
    Obasaju, C. K.
    Treat, J.
    Milton, D.
    Bonomi, P. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] An indirect comparison of the efficacy of bevacizumab plus carboplatin and paclitaxel versus pemetrexed with cisplatin in patients with advanced or recurrent non-squamous adenocarcinoma non-small cell lung cancer
    Nuijten, Mark J. C.
    Aultman, Rick
    de Castro Carpeno, Javier
    Vergnenegre, Alain
    Chouaid, Christos
    Walzer, Stefan
    Siebert, Uwe
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (11) : 2193 - 2201